Acurx pharmaceuticals to present at the emerging growth conference on august 18, 2021

Staten island, n.y. , aug. 12, 2021 /prnewswire/ -- acurx pharmaceuticals, inc. (nasdaq: acxp) ("acurx" or the "company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that david p.

ACXP Ratings Summary

ACXP Quant Ranking